During the past decade, Klinikum Darmstadt conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Darmstadt" #1 sponsor was "University of Ulm" with 7 trials, followed by "Celgene" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "University Hospital Tuebingen" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Darmstadt" #1 collaborator was "Klinikum Darmstadt" with 2 trials as a collaborator, "Klinikum Stuttgart" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Asahi Intecc Co., Ltd." with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Darmstadt" are "Acute Myeloid Leukemia" (3 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Crohn Disease" (3 trials), "Lymphoma" (3 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Klinikum Darmstadt" in a lesser frequency.

Most popular intervention types in "Klinikum Darmstadt" are "Drug" (27 trials), "Device" (8 trials), "Biological" (7 trials), "Other" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cytarabine" (4 trials), "Ozanimod" (3 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Darmstadt" are 42 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Darmstadt". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Klinikum Darmstadt, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Darmstadt, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Klinikum Darmstadt has several departments that took part in Clinical trials: "Klinikum Darmstadt GmbH; Med. Klinik V; Onkologie & Hämatologie" - 5 trials, "Onkologisches Studienzentrum Darmstadt" - 2 trials